Literature DB >> 15106119

Global measles elimination efforts: the significance of measles elimination in the United States.

Peter M Strebel1, Ana-Maria Henao-Restrepo, Edward Hoekstra, Jean-Marc Olive, Mark J Papania, Stephen L Cochi.   

Abstract

Lessons learned from the successful end of endemic measles virus transmission (i.e., elimination) in the United States include the critical roles of strong political commitment, a regionwide initiative, adequate funding, and a broad coalition of partners. Implications of measles elimination in the United States for global measles control and regional elimination efforts include demonstration of the high vaccination coverage and, in turn, population immunity needed for elimination; the importance of accurate monitoring of vaccination coverage at local, state, and national levels; a vaccination strategy that includes at least 2 opportunities for measles immunization; and the essential role of integrated epidemiological and laboratory surveillance. The United States, with a population of 288 million, is, to our knowledge, the largest country to have ended endemic measles transmission. This experience provides evidence that sustained interruption of transmission can be achieved in large geographic areas, suggesting the feasibility of global eradication of measles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106119     DOI: 10.1086/378092

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Measles vaccine immune escape: Should we be concerned?

Authors:  Luojun Yang; Bryan T Grenfell; Michael J Mina
Journal:  Eur J Epidemiol       Date:  2019-11-01       Impact factor: 8.082

2.  The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines?

Authors:  Gregory A Poland; Robert M Jacobson
Journal:  Vaccine       Date:  2012-01-05       Impact factor: 3.641

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

5.  Qualitative Variation among Commercial Immunoassays for Detection of Measles-Specific IgG.

Authors:  Donald R Latner; Sun B Sowers; Kiana Anthony; Heather Colley; Christine Badeau; Jessica Coates; Phili Wong; Yetunde Fakile; Cristina Interiano; Kevin B Pannell; Van Leung-Pineda; Manisha M Patel; Paul A Rota; Brandi M Limbago; Carole J Hickman
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

6.  Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Authors:  Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
Journal:  BMC Infect Dis       Date:  2015-01-22       Impact factor: 3.090

7.  Age-specific mixing generates transient outbreak risk following critical-level vaccination.

Authors:  S Bhattacharyya; M J Ferrari
Journal:  Epidemiol Infect       Date:  2016-09-28       Impact factor: 4.434

Review 8.  The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.

Authors:  Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

9.  Nuclear reprogramming with a non-integrating human RNA virus.

Authors:  Christopher B Driscoll; Jason M Tonne; Moustafa El Khatib; Roberto Cattaneo; Yasuhiro Ikeda; Patricia Devaux
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

10.  Progress towards elimination of measles in Kenya, 2003-2016.

Authors:  Ngina Kisangau; Kibet Sergon; Yusuf Ibrahim; Florence Yonga; Daniel Langat; Rosemary Nzunza; Peter Borus; Tura Galgalo; Sara A Lowther
Journal:  Pan Afr Med J       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.